High-quality dialysis: A lesson from the Japanese experience

NDT Plus

Volumn 3, Issue SUPPL. 1, 2010, Pages

  Masakane, Ikuto ^a  

^a Yabuki Shima Clinic   (Japan)

Author keywords

biocompatibility; nutrition; PMMA; POD system

Indexed keywords

DIALYSIS FLUID; ETHYLENE VINYL ALCOHOL COPOLYMER; POLY(METHYL METHACRYLATE); POLYSULFONE;

AMYLOIDOSIS; ATHEROSCLEROSIS; BACTERIUM CONTAMINATION; BIOCOMPATIBILITY; DEPRESSION; DIALYSIS; HEALTH CARE QUALITY; HEMODIAFILTRATION; HUMAN; HYPOTENSION; INFLAMMATION; INSOMNIA; IRRITABILITY; JAPANESE; MALNUTRITION; MOLECULAR WEIGHT; NUTRITIONAL STATUS; PATIENT ATTITUDE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SURVIVAL RATE; UREMIC PURITUS; WEIGHT REDUCTION;

EID: 77956053969     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq034     Document Type: Review

References (36)

1. Tsubakihara Y. An overview of regular dialysis treatment in Japan as of Dec. 31, 2006. Tokyo: Japanese Society for Dialysis Therapy, 2007; 3
2. Gejyo F, Odani S, Yamada T et al. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30: 385-390
3. Koda Y, Nishi S, Miyazaki S et al. Switch from conventional to highflux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997; 52: 1096-1101
4. Masakane I. Review: Clinical usefulness of ultrapure dialysate- recent evidence and perspectives. Ther Apher Dial 2006; 10: 348-354
5. Stenvinkel P, Heimuburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
6. Colton CK, Ward RA, Shaldon S. Scientific basis for assessment of biocompatibility in extracorporeal blood treatment. Nephrol Dial Transplant 1994; 9: 11-17
7. Pisoni R, Wirkstoem B, Akizawa T et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505
8. Lopes AA, Albert JM, Young EW et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 2004; 66: 2047-2053
9. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
10. Lowrie EG, Zhu X, Lew NL. Primary associates of mortality among dialysis patients: trends and reassessment of Kt/V and urea reduction ratio as outcome-based measures of dialysis dose. Am J Kidney Dis 1998; 32: S16-S31
11. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277
12. Cheung AK, Rocco MV, Yan G et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555
13. Okuno S, Ishimura E, Kohno Ket al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24: 571-577
14. Vincent C, Revillard JP, Galland M et al. Serum beta2-microglobulin in hemodialyzed patients. Nephron 1978; 21: 260-268
15. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-1148
16. Kalantar-Zadeh K, Kopple JD, Block G et al. A malnutritioninflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263
17. Port FK, Ashby VB, Dhingra RK, Rogs EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066
18. Baz M, Durand C, Ragon A et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991; 14: 681-685
19. Schiffl H, Lang SM, Bergner A. Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron 1999; 83: 278-279
20. Schiffl H, Lang SM, Stratakis D et al. Effects of ultrapure dialysate fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 2001; 16: 1863-1869
21. Masakane I, Tsubakihara Y, Akiba T et al. Bacteriological qualities of dialysis fluid in Japan as of 31 December 2006. Ther Apher Dial 2008; 12: 457-463
22. Kawanisi H, Akiba T, Masakane I et al. The standard on bacterial management of fluids for hemodialysis and related therapies from Japanese Society for Dialysis Therapy (JSDT) 2008. Ther Apher Dial 2009; 13: 161-166
23. Masakane I, Nakai S, Akiba T et al. Bacteriological water quality has a strong impact on the outcome of chronic dialyzed patients. J Am Soc Nephrol 2008; 19: 693A
24. Masakane I, Seki H, Atsumi R et al. On-line hemodiafiltration is effective to keep muscle volume in CKD patients. Blood Purif 2005; 23: 404
25. Muta T, Fujimoto T, Harada Y et al. Are there any differences on amino acid loss during dialysis session by the dialysis membrane material? Kidney and Dial 59 (suppl) High Performance Membrane '05 2005; 241-244 (in Japanese)
26. Masakane I, Kaneda H, Esashi S. PMMA is more desirable for elder dialysis patients than PS. Kidney and Dial 63 (suppl) High Performance Membrane '07 2007; 202-203 (in Japanese)
27. Bamments B, Evnepoel P, Verbeke K et al. Removal of the proteinbound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 2004; 44: 278-285
28. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001; 60: 358-363
29. Saito A, Suzuki L, Chung TG et al. Separation of an inhibitor of erythropoiesis in "Middle molecules" from hemodialysis from patients with chronic renal failure. Clin Chem 1986; 32: 1938-1941
30. Yamada S, Kataoka H, Kobayashi H, Ono T, Minakuchi J, Kawano Y. Identification of erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F) and its clinical effects. Contrib Nephrol 1998; 125: 159-172
31. Ohashi N, Yonemura K, Goto T et al. A case of anaphylactoid shock induced by the BS polysulfone hemodialyzer but not by the F8-HPS polysulfone hemodialyzer. Clin Nephrol 2003; 60: 214-217
32. Shin S, Nishioka M, Shinko S et al. Side effects caused by PS membrane. Kidney and Dial 63 (suppl) High Performance Membrane '07 2007; 275-279 (in Japanese)
33. Narita I, Alchi B, Omori K et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006; 69: 1626-1632
34. Elder SJ, Pisoni RL, Akizawa T et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008; 23: 998-1004
35. Tsubakihara Y. An overview of regular dialysis treatment in Japan as of Dec. 31, 2007 (CD ROM) Tokyo. Japanese Society for Dialysis Therapy 2007; Table 207
36. Masakane I, Ito S. What is the most important factor to improve the survival rate of elder dialysis patients? J Am Soc Nephrol 2009; 20: 678A